Sankalp Arora, Hagop Kantarjian, Manuel Maroun, Gautam Borthakur, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Ghayas Issa, Kelly Chien, Abhishek Maiti, Maro Ohanian, Mahesh Swaminathan, Wei-Ying Jen, Farhad Ravandi, Hussein Abbas, Nicholas Short. "A Phase II study of azacitidine, venetoclax, and gilteritinib for newly diagnosed adverse risk FLT3-wild type acute myeloid leukemia." Blood, 2025. doi:10.1182/blood-2025-5226